Nemes Rush Group LLC Novartis Ag Transaction History
Nemes Rush Group LLC
- $728 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,425Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.46 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.45 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$885 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$884 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$710 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $257B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...